BiotechTube

Lanthanum Carbonate (Fosrenol, BAY77-1931) - chewable tablet

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
20
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hyperphosphatemia

Conditions

Hyperphosphatemia

Trial Timeline

Apr 7, 2009 → Sep 1, 2016

NCT ID
NCT01412398

About Lanthanum Carbonate (Fosrenol, BAY77-1931) - chewable tablet

Lanthanum Carbonate (Fosrenol, BAY77-1931) - chewable tablet is a pre-clinical stage product being developed by Bayer for Hyperphosphatemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01412398. Target conditions include Hyperphosphatemia.

Hype Score Breakdown

Clinical
5
Activity
2
Company
7
Novelty
2
Community
1

Clinical Trials (2)

NCT IDPhaseStatus
NCT01412398Pre-clinicalCompleted
NCT01419327Pre-clinicalCompleted

Competing Products

20 competing products in Hyperphosphatemia

See all competitors
ProductCompanyStageHype Score
EOS789 + Placebo + RenvelaChugai PharmaceuticalPhase 1
33
DS-2330b PIB + Placebo + Sevelamer + DS-2330b TabletDaiichi SankyoPhase 1
33
ASP1585 + Placebo + Sevelamer hydrochlorideAstellas PharmaPhase 2
52
ASP1585Astellas PharmaPhase 2
52
the standard-dose group (4 g/day)Kyowa KirinPre-clinical
23
KHK7791 + PlacebpKyowa KirinPhase 2
52
KHK7791Kyowa KirinPhase 2
52
KHK7791 + PlaceboKyowa KirinPhase 3
77
the low-dose group (1.5 g/day) or the standard-dose group (4 g/day)Kyowa KirinPre-clinical
23
KHK7791 + PlaceboKyowa KirinPhase 3
77
KHK7791Kyowa KirinPhase 3
77
KHK7791 + PlaceboKyowa KirinPhase 2
52
KHK7791Kyowa KirinPhase 3
77
SBR759 + Sevelamer HCl + SBR759 + Sevelamer HClNovartisPhase 2
52
SBR759A + SBR759A + SBR759A + SBR759A + SBR759ANovartisPhase 3
77
PA21Kissei PharmaceuticalPhase 3
76
Placebo + Sevelamer Carbonate (GZ419831)SanofiPhase 3
76
Placebo + Sevelamer carbonateSanofiPhase 2
51
Lanthanum Carbonate (Fosrenol, BAY77-1931)BayerPre-clinical
20
Lanthanum Carbonate (BAY77-1931)BayerPhase 2
49

Other Products from Bayer

TelmisartanApproved
82
Clotrimazole vaginal tablet + FluconazoleApproved
82
Levitra (Vardenafil, BAY38-9456)Approved
82
Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved
82
Rivaroxaban 20 MG + WarfarinApproved
82